病例分享丨晚期肝癌入组ABSK011一个月，效果如何？_老虎社区_美港股上老虎

病例分享丨晚期肝癌入组ABSK011一个月，效果如何？

和誉医药
05-29

清华长庚医院黎功主任分享：晚期肝癌患者接受 $和誉-B(02256)$ 自主研发的小分子FGFR4抑制剂依帕戈替尼（ABSK011）治疗1个月后，肿瘤直径缩小42%，甲胎蛋白、异常凝血酶原等肿瘤指标均大幅下降！

$和誉-B(02256)$

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":569412875247960,"tweetId":"569412875247960","gmtCreate":1780021018878,"gmtModify":1780022690344,"author":{"id":4143269081778110,"idStr":"4143269081778110","authorId":4143269081778110,"authorIdStr":"4143269081778110","name":"和誉医药","avatar":"https://static.tigerbbs.com/adb09e4e1f90e3f4deff5b93da1d691a","vip":5,"userType":5,"introduction":"和誉-B（2256.HK）专注于肿瘤创新药物研发，致力于改善中国及全球病人的生活质量。 ","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1779,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[{"img":"https://static.tigerbbs.com/95492a1e2d6930a70d8c51c1454f9c65"}],"title":"病例分享丨晚期肝癌入组ABSK011一个月，效果如何？","html":"<html><head></head><body>清华长庚医院黎功主任分享：晚期肝癌患者接受 <a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a> 自主研发的小分子FGFR4抑制剂依帕戈替尼（ABSK011）治疗1个月后，肿瘤直径缩小42%，甲胎蛋白、异常凝血酶原等肿瘤指标均大幅下降！\n<video poster=\"https://static.tigerbbs.com/95492a1e2d6930a70d8c51c1454f9c65\" tg-width=\"544\" tg-height=\"967\" class=\"ql-video te-video-limit\" controls=\"true\" controlslist=\"nodownload\" playsinline=\"true\" webkit-playsinline=\"true\">\n <source src=\"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/8ea7478f5145403727877749271/6AUhaJOpAZ8A.mp4\">\n</video>\n<a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a></body></html>","htmlText":"<html><head></head><body>清华长庚医院黎功主任分享：晚期肝癌患者接受 <a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a> 自主研发的小分子FGFR4抑制剂依帕戈替尼（ABSK011）治疗1个月后，肿瘤直径缩小42%，甲胎蛋白、异常凝血酶原等肿瘤指标均大幅下降！\n<video poster=\"https://static.tigerbbs.com/95492a1e2d6930a70d8c51c1454f9c65\" tg-width=\"544\" tg-height=\"967\" class=\"ql-video te-video-limit\" controls=\"true\" controlslist=\"nodownload\" playsinline=\"true\" webkit-playsinline=\"true\">\n <source src=\"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/8ea7478f5145403727877749271/6AUhaJOpAZ8A.mp4\">\n</video>\n<a href=\"https://laohu8.com/S/02256\">$和誉-B(02256)$</a></body></html>","text":"清华长庚医院黎功主任分享：晚期肝癌患者接受 $和誉-B(02256)$ 自主研发的小分子FGFR4抑制剂依帕戈替尼（ABSK011）治疗1个月后，肿瘤直径缩小42%，甲胎蛋白、异常凝血酶原等肿瘤指标均大幅下降！ $和誉-B(02256)$","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/569412875247960","repostId":0,"isVote":1,"tweetType":2,"object":{"id":"693e5bb9f9d3497096cd6d752f1a3ceb","videoUrl":"https://1254107296.vod2.myqcloud.com/e2ad4227vodcq1254107296/8ea7478f5145403727877749271/6AUhaJOpAZ8A.mp4","poster":"https://static.tigerbbs.com/95492a1e2d6930a70d8c51c1454f9c65","desc":""},"viewCount":53895,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02256"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":187,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}